跳至主要内容
临床试验/NCT02230137
NCT02230137已完成不适用

Impact of Mobile Phone Short Text Messages on the Glycaemic Control of Adolescents With Poorly Controlled Type 1 Diabetes.

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2015年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
1
主要终点
HbA1c level

研究概览

简要总结

The purpose of this study is to assess HbA1c reduction after supportive care by SMS among adolescents with poorly controlled type 1 diabetes.

详细描述

In 2010, the number of children with type 1 diabetes in France is estimated at 12,000 with 60% of them aged 12 to 17 years. Compliance is a major issue during adolescence. Mobile text message is one of the strategies to enhance adherence. The main aim of this study is to assess HbA1c reduction after a 6 month SMS support among adolescents with poorly controlled type 1 diabetes. Adherence and quality of life will also be assessed at the end of the trial. This study is a prospective randomized monocentric trial. Sixty adolescents with type 1 diabetes and HbA1c equal or higher than 8.5 % will be randomized according to the method of Zelen in two groups : standard treatment versus standard treatment plus support by SMS. The patients will receive one SMS before each injection of insulin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
12 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •aged between 12 and 21 years old
  • •with type 1 diabetes for more than 6 months
  • •HbA1c at enrollment > 8.5%
  • •non-opposition of one of the parents
  • •previous medical exam (art. L.1121-11 du CSP)
  • •Possible follow-up for 6 months
  • •social welfare coverage
  • •Adolescents with a mobile phone, able to receive short text message

排除标准

  • •aged less than 12 or higher than 21 years old
  • •with HbA1c at enrollment < 8.5%
  • •pregnancy
  • •psychiatric disease
  • •do not understand french

研究组 & 干预措施

Text message arm

Experimental

干预措施: Text message arm (Behavioral)

No text message arm

No Intervention

结局指标

主要结局

HbA1c level

时间窗: 6 months

次要结局

  • Quality of life(6 months)
  • Compliance(3 months)
  • Quality of life(3 months)
  • HbA1c level(3 months)
  • Compliance(6 months)
  • Satisfaction survey(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验